The National Council Approves the Princely Government’s Bill on Vaccination Requirements

Dr Christophe Robino: Driving Health Policy and Turning Science into Public Action

Building on the scientific expertise provided by specialists, Dr Christophe Robino, Minister of Health and Social Affairs, has played a decisive role in translating this knowledge into concrete and sustainable measures.

A strong advocate for an ambitious modernization of vaccination policy, Dr Robino regularly recalls that vaccination is “one of the most effective ways to protect children’s health.” He supported the legislative reform by emphasizing:

- the need to align Monaco with the highest international standards,

- the importance of ensuring free access to essential vaccines, including the HPV vaccine,

- the strengthening of vaccination campaigns in schools,

- clear communication to support families and counter misconceptions.

Under his leadership, Monaco’s strategy aims not only to maintain high coverage rates, but also to anticipate future challenges by integrating new scientific data on cancer prevention.

Why Has HPV Vaccination Become a Priority?

Human papillomavirus (HPV) is widely recognized as one of the main infectious agents responsible for preventable cancers. While it is strongly associated with cervical cancer, it is also involved in:

- oropharyngeal cancers,

- anal cancers,

- vulvar and vaginal cancers,

- certain penile cancers.

Vaccination, particularly effective when administered before exposure to the virus, has already shown in several countries a significant reduction in precancerous lesions and a decrease in HPV circulation.

The upcoming integration of the HPV vaccine into mandatory vaccinations is therefore part of a modern, ambitious, and scientifically grounded public health approach.

A Principality Ahead of its Time: Prevention, Science, and Governance United

The convergence between the work of the scientific community and the strategic vision of Dr Robino positions Monaco as a pioneer in cancer prevention.

The 2025 reform marks:

- the necessary update of an outdated legal framework,

- the strengthening of a coherent, forward-looking vaccination policy,

- the commitment to integrating recent vaccines with strong preventive value,

- a clear dedication to the long-term reduction of HPV-related cancers.

By investing in prevention from childhood, Monaco establishes itself as a regional model in proactive public health.

Prevent Today to Protect Tomorrow

The Principality’s vaccination strategy now relies on two complementary pillars:

- scientific rigor,

- political and administrative vision, embodied by Dr Christophe Robino.

Together, they contribute to implementing an innovative policy aimed at protecting future generations from preventable HPV-related cancers.